Innovative berry-based skin spray targets hospital-acquired bacteria

FHS
August 28, 2024
11:34 am

VTT has developed a skin spray, based on nanocellulose and antimicrobial compounds from wild berries, which can be used to treat wounds and eliminate hospital-acquired bacteria such as MRSA before surgery.

JAPAC Drug Development: Safety & Regulatory Requirements

Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia

April 16, 2024

Lab group urges lawmakers to rescind FDA final rule on LDTs

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Association for Diagnostics and

September 9, 2024

New wireless biosensor technology could revolutionize healthcare

A wireless biosensor, developed by a Malmö University researcher, enables a more patient-controlled system whereby infections can be detected much earlier through smart catheters, smart

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.